Multiplexed Engineering of CD19CAR T Cells for Post-Transplant Consolidative Immunotherapy
Corinne Summers(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Colleen Delaney(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Alexandra E. Grier
Cited by 4
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754